Creative Capital Management Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Creative Capital Management Investments’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.7K	Hold	24	–	–	﹤0.01%	206
2025 Q4	$10.9K	Hold	24	–	–	﹤0.01%	208
2025 Q3	$9.4K	Hold	24	–	–	﹤0.01%	200
2025 Q2	$10.7K	Hold	24	–	–	﹤0.01%	212
2025 Q1	$11.6K	Hold	24	–	–	﹤0.01%	181
2024 Q4	$9.66K	Hold	24	–	–	﹤0.01%	192
2024 Q3	$11.2K	Hold	24	–	–	﹤0.01%	163
2024 Q2	$11.2K	Hold	24	–	–	0.01%	160
2024 Q1	$10K	Hold	24	–	–	0.01%	155
2023 Q4	$9.77K	Hold	24	–	–	0.01%	152
2023 Q3	$8.35K	Hold	24	–	–	0.01%	162
2023 Q2	$8.45K	Hold	24	–	–	0.01%	152
2023 Q1	$7.56K	Hold	24	–	–	0.01%	171
2022 Q4	$7K	Buy	+24	New	+$7.31K	0.01%	135

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Creative Capital Management Investments's VRTX Position: Q1 2026 in Review

Creative Capital Management Investments held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 24 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #206.

Creative Capital Management Investments first reported a position in VRTX in Q4 2022 and has held it in 14 quarters since. The position peaked at $11.6K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Creative Capital Management Investments held 24 shares of Vertex Pharmaceuticals worth $10.7K as of Q1 2026.
Creative Capital Management Investments left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
Vertex Pharmaceuticals made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q1 2026, its #206 holding.
Creative Capital Management Investments first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
Creative Capital Management Investments's Vertex Pharmaceuticals position peaked at $11.6K in Q1 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Creative Capital Management Investments's 13F filing for Q1 2026, filed 21 Apr 2026.